# The Efficacy of Systemic Valacyclovir (Valtrex) on Periodontitis

> **NCT05712343** · EARLY_PHASE1 · UNKNOWN · sponsor: **University of California, San Francisco** · enrollment: 40 (estimated)

## Conditions studied

- Severe Periodontitis

## Interventions

- **DRUG:** Valacyclovir group
- **OTHER:** Control group

## Key facts

- **NCT ID:** NCT05712343
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-05-25
- **Primary completion:** 2024-03-01
- **Final completion:** 2024-03-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2023-07-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05712343

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05712343, "The Efficacy of Systemic Valacyclovir (Valtrex) on Periodontitis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05712343. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*